Skip to Main Content

What a difference a few months make.

Just eight months after joining a small but growing list of drug makers that vowed to limit price hikes, AbbVie (ABBV) appears to be backing away from its pledge.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!